Results 61 to 70 of about 812 (121)
Development and Evaluation of Gastroretentive Atenolol Tablets
Zagazig Journal of Pharmaceutical Sciences, 2014 The low oral bioavailability of atenolol is primarily because of its poor absorption from the lower gastrointestinal tract. Gastroretentive dosage forms provide an opportunity to deliver the drug with absorption window in the proximal part of the GIT ...
Rachna kumria +4 more
doaj +1 more source
Association between beta‐blocker atenolol use and prostate cancer upgrading in active surveillance1
BJUI CompassObjectives The objective of this study is to investigate the association between the use of beta‐adrenergic antagonist atenolol and risk of pathologic upgrade in patients on active surveillance, considering growing literature implicating adrenergic ...
Ali H. Zahalka +12 more
doaj +1 more source
Future Journal of Pharmaceutical Sciences, 2018 The potential of proniosomes as a transdermal drug delivery system for Atenolol was investigated by encapsulating the drug in various formulations of proniosomal gel composed of various ratios of sorbitan fatty acid esters, cholesterol, lecithin prepared
S. Ramkanth +5 more
doaj +1 more source
Кардиоваскулярная терапия и профилактика, 1970 Aim. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study was a double-blind trial in patients with hypertension at increased cardiovascular risk with carotid wall thickening and a defined atherosclerotic plaque that used non ...
Kl. O. Stumpe +7 more
doaj
Journal of Electrochemical Science and EngineeringAtenolol, one of the most prescribed β₁-selective adrenergic blockers, has been increasingly detected in aquatic ecosystems due to incomplete elimination in sewage treatment plants, posing an ecotoxicological hazard to the environment.
Nevila Broli +5 more
doaj +1 more source
ROLE OF BLOOD PRESSURE REDUCTION IN PREVENTION OF CARDIAC AND VASCULAR HYPERTROPHY
Российский кардиологический журнал, 2011 We investigated whether prevention of cardiac and vascular remodelling associated with inhibition of angiotensin II is independent of the blood pressure (BP) lowering action of angiotensin II type 1 (AT1) receptor blockade.
H. Yokoyama +5 more
doaj
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Atenolol for Migraine Prophylaxis
Headache: The Journal of Head and Face Pain, 1983SYNOPSIS The preventive effect of atenolol on migraine attacks was compared to placebo in a double‐blind cross‐over study. 24 patients with classic and/or common migraine entered the 36‐week study; four subsequently dropped out. The effect of atenolol was significantly better than that of placebo.
B, Forssman +2 more
openaire +2 more sources